TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Announces GMP Manufacturing Agreement
March 17th, 2009
Aethlon Medical, Inc. (OTCBB:AEMD) announced it has entered into a non-exclusive agreement with Bioserv Corporation dba NextPharma Technologies, to establish manufacturing of the Aethlon Hemopurifier® under good manufacturing practice (GMP) requirements set forth in quality system (QS) regulations for medical device commercialization. The Hemopurifier® is a first-in-class medical device that assists the immune response in combating infectious disease through real-time therapeutic filtration of infectious viruses and immunosuppressive proteins from the entire circulatory system. Safety of the Hemopurifier® has been demonstrated in multi-site human studies, with robust viral load reductions...
Source: TB & Outbreaks Week (2009-03-17)
|
